Be the sponsor of this project! Osteosarcoma is a disease for which local control can be critical:  for tumors in a limb, local control permits

This multi-disciplinary approach to accelerating discovery of therapies for childhood cancer is made possible by a joint effort of our scientific director Dr. Keller and our Board member, Sunit Rikhi, former VP of the Intel custom foundry. Together, our teams of biologists and engineers will maximize automation and the design of new devices and biomaterials that address challenges in the treatment of cancer as well as prevention of recurrence, ultimately improving outcomes for children with cancer.

Alveolar rhabdomyosarcoma is a cancer of the soft tissues. Local control for rhabdomyosarcoma is an important clinical challenge, and recurrence at the tumor resection bed can be a gateway to progression and metastasis. Our project seeks to put the types of cutting edge, non-chemotherapy medicines used by internists into the hands of the surgeon for the purpose of preventing local recurrence at the earliest possible moment.

Be the sponsor of this project!  One in 5 children with cancer will not survive. We propose to address gaps in basic and translational research

The goal of this preclinical study is to validate marizomib as a treatment for medulloblastoma.

Be the sponsor of this project! What if an FDA-approved dermatitis and asthma medicine could stop rhabdomyosarcoma metastasis?  The major goal of this project is

Be the sponsor for this project! We have investigated presence of the IL13RA2 protein in DIPG, and we have shown there is 13 times higher